The synergistic inhibition of tumor growth by Oxali + anti–PD-L1 was completely abrogated by p300 and CBP ablation in Myc-CaP cells (Fig. 7 D–G and SI Appendix, Fig. S15A). Here, EP300 is linked to neoplasm.